Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872118 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 8 Pages |
Abstract
Conclusion: The risk of treatment failure in advanced-stage cervical cancer patients treated by RT alone can be more precisely predicted by risk stratification. A certain subgroup of patients had better control than the others. The benefit of treating these relatively low-risk patients with additional treatment such as concurrent chemotherapy should be further evaluated in prospective studies or meta-analyses.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Ji-Hong M.D., Ph.D., Chien-Sheng M.D., Chyong-Huey M.D., Ting-Chang M.D., Chun-Chieh M.D., Hung-Hsueh M.D., Steve P. M.D., Ph.D., Chung-Chi Ph.D., Simon G. M.D., Swei M.D.,